Southeastern Retina Associates PC

08/27/2026

Wondering what happens during a fluorescein angiography test? This imaging test uses a special dye and camera to help retina specialists examine the blood vessels in your retina and detect conditions like diabetic retinopathy, retinal vein occlusion, and age-related macular degeneration. The procedure is quick, and most patients experience only minimal discomfort. Learn more: https://www.southeasternretina.com/blog/what-happens-during-a-fluorescein-angiography-test

Fluorescein angiography is an effective diagnostic test used to identify retinal conditions like diabetic retinopathy and AMD. Learn more here.

08/25/2026

Quality retina care is close to home in Morristown. Our experienced retina specialists provide expert diagnosis and treatment for a wide range of retinal conditions, including age-related macular degeneration, diabetic retinopathy, retinal tears, retinal detachment, and more. Learn more: https://www.southeasternretina.com/retina-centers/morristown

08/20/2026

Many eye tumors cause few or no symptoms in their early stages, making routine eye exams especially important. While eye cancers are rare, early detection can help lead to timely diagnosis and treatment. Learn more:

Get advanced ocular oncology care in Chattanooga, Knoxville, Tri-Cities, and beyond with Southeast Retina Associates. Trust us for exceptional ocular oncology care.

08/18/2026

Meet Dr. Rui Wang, a board-certified ophthalmologist and fellowship-trained retina specialist joining Southeastern Retina Associates this September. Dr. Wang completed his vitreoretinal surgery fellowship at The Retina Institute in St. Louis and has contributed to numerous clinical research studies focused on advancing treatments for retinal diseases. He looks forward to providing compassionate, expert care to patients throughout our region. Learn more: https://www.southeasternretina.com/retina-specialists/rui-wang-m-d

08/13/2026

New research highlights the importance of monitoring children with high myopia (severe nearsightedness). Researchers found that more than half of children with high myopia had changes in the peripheral retina, and the likelihood increased with age and worsening nearsightedness. Regular eye exams and early detection can help identify retinal changes before they lead to more serious complications. Learn more: https://www.ophthalmologytimes.com/view/detecting-peripheral-retinal-lesions-in-children-with-myopia

Ultra-widefield imaging reveals early retinal risk in pediatric patients.

08/11/2026

Meet Dr. Cris Larzo, a board-certified retina specialist serving patients throughout the Tri-Cities region. Before joining Southeastern Retina Associates in 2011, he served as director of vitreoretinal service and fellowship at West Virginia University and contributed to research in gene therapy for childhood blindness. Today, he is dedicated to providing compassionate, expert care for patients with retinal diseases. Learn more: https://www.southeasternretina.com/retina-specialists/dr-cris-larzo

08/06/2026

Struggling to see clearly at night? While some changes in night vision can come with age, persistent difficulty seeing in low light could be a sign of an underlying retinal condition. Learn what’s normal, what’s not, and when to seek care in our blog: https://www.southeasternretina.com/blog/night-vision-problems-and-the-retina-what-s-normal-and-what-s-not

08/05/2026

Dr. Devon Ghodasra recently joined the RetinUp podcast to discuss how biosimilars are being incorporated into retina care. In the episode, he shares insights on evaluating new treatments, communicating with patients, and implementing biosimilars in clinical practice. Listen to the full episode: https://www.southeasternretina.com/blog/listen-devon-ghodasra-md-on-biosimilars-in-practice

08/04/2026

Researchers have taken an important step toward a potential new treatment for Stargardt disease, a rare inherited eye condition that can cause progressive vision loss. A once-daily pill is now under FDA review and, if approved, could become the first available treatment for people living with this condition. Learn more: https://www.ophthalmologytimes.com/view/tinlarebant-nda-submission-completed-stargardt-disease

Belite Bio has completed its rolling NDA submission to the FDA for tinlarebant, a potential first approved treatment for Stargardt disease type 1.

07/30/2026

A new study found that temporary vision loss could be an early warning sign of serious health issues, including stroke and heart disease. If you experience sudden vision loss, even if it goes away quickly, seek medical care right away to help protect both your vision and your overall health. Learn more: https://www.ophthalmologytimes.com/view/transient-visual-loss-linked-to-elevated-cardiovascular-and-stroke-risk-for-up-to-a-decade

Transient vision loss may foreshadow stroke or heart events; study urges urgent 90-day evaluation and long-term cardiovascular monitoring.